South Dakota Investment Council Sells 37,006 Shares of Pediatrix Medical Group, Inc. $MD

South Dakota Investment Council trimmed its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 46.5% in the second quarter, according to its most recent filing with the SEC. The fund owned 42,648 shares of the company’s stock after selling 37,006 shares during the period. South Dakota Investment Council’s holdings in Pediatrix Medical Group were worth $612,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of MD. GAMMA Investing LLC lifted its stake in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock valued at $37,000 after acquiring an additional 1,765 shares during the last quarter. Marshall & Sullivan Inc. WA bought a new position in shares of Pediatrix Medical Group in the 2nd quarter valued at $41,000. AlphaQuest LLC lifted its stake in shares of Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock valued at $85,000 after acquiring an additional 811 shares during the last quarter. Freedom Investment Management Inc. bought a new position in shares of Pediatrix Medical Group in the 2nd quarter valued at $151,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in shares of Pediatrix Medical Group in the 1st quarter valued at $159,000. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Stock Performance

Shares of MD opened at $21.39 on Wednesday. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $1.86 billion, a P/E ratio of 16.58 and a beta of 1.26. The firm’s fifty day simple moving average is $17.01 and its two-hundred day simple moving average is $14.95. Pediatrix Medical Group, Inc. has a 12 month low of $11.84 and a 12 month high of $22.38.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.67 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.21. The business had revenue of $492.88 million for the quarter, compared to analysts’ expectations of $476.45 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business’s quarterly revenue was down 3.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.44 earnings per share. As a group, analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. Wall Street Zen upgraded Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 4th. Truist Financial set a $17.00 price objective on Pediatrix Medical Group in a report on Tuesday, October 14th. Zacks Research downgraded Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 7th. UBS Group increased their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a report on Thursday, August 14th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Pediatrix Medical Group in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Pediatrix Medical Group has an average rating of “Hold” and a consensus target price of $17.10.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.